MEDS — DataMeds AI Cashflow Statement
0.000.00%
Last trade - 00:00- $11.01m
- $40.36m
- $23.34m
Annual cashflow statement for DataMeds AI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.005 | -2.9 | -6.86 | -101 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | — | — | 1.17 | 72.7 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.005 | 2.55 | 3.34 | 14.5 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | 0 | -0.349 | -1.22 | -10.9 |
| Capital Expenditures | — | — | -0.377 | -0.882 |
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | — | — | 0.846 | — |
| Sale of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | — | — | 0.469 | -0.882 |
| Financing Cash Flow Items | 0 | 0.001 | 1.15 | -0.842 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0 | 0.35 | 1.78 | 10.8 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0 | 0.001 | 1.03 | -0.986 |